T-cell receptor-CD3 zeta-associated signalosome (TCR-CD3ζ signalosome) (TCR-CD3ζ signalosome)

The T-cell receptor-CD3 zeta-associated signalosome (TCR-CD3ζ signalosome) is a complex multi-protein assembly that forms at the plasma membrane of T-cells upon the recognition of an antigen-MHC complex. The core of this signalosome is the CD3 zeta (ζ) chain, also known as CD247, which contains multiple immunoreceptor tyrosine-based activation motifs (ITAMs) that are phosphorylated by the Src-family kinase Lck upon TCR engagement [1, 2]. These phosphorylated ITAMs serve as high-affinity docking sites for the tandem SH2 domains of the kinase ZAP-70, which then phosphorylates downstream adaptor proteins such as the Linker for Activation of T-cells (LAT) and SLP-76 [3, 4]. This assembly acts as a critical signaling hub, integrating and amplifying signals required for T-cell activation, proliferation, and the production of effector cytokines like IL-2 [2, 5]. In clinical practice, this signalosome is a major therapeutic target; for example, anti-CD3 monoclonal antibodies like Teplizumab are used to induce immune tolerance in autoimmune conditions such as Type 1 Diabetes by modulating TCR signaling [6, 7]. Additionally, small molecule inhibitors like Dasatinib can disrupt the signalosome by inhibiting Lck, thereby preventing the initiation of the signaling cascade [8]. Dysregulation of the components within this signalosome is associated with severe combined immunodeficiency (SCID) and various autoimmune or lymphoproliferative disorders [1, 9].

Other names

CD3 zeta signalosomeCD247-associated signalosomeT-cell receptor signaling complexTCR/CD3 complex signalosomeCD3z-associated TCR signalosome

Modulation of T-cell activation through binding of CD3 subunits to induce receptor internalization or blocking of antigen recognition, and inhibition of associated tyrosine kinases like Lck and ZAP-70 to prevent the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) and subsequent downstream signaling.